Clinical Trials Browser

Phase 1 × Unknown × binimetinib × Clear all

NCT05103891 2021-12-01

Relative Bioavailability of Binimetinib 3 x 15 mg and 45 mg Formulations

Phase 1 Unknown

Melanoma